This inventor holds 1 USPTO granted patent. Top assignee: Aveo Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Michael Deprima
Introduction
Michael Deprima is a notable inventor recognized for his contributions to the field of biotechnology. He is currently associated with Aveo Pharmaceuticals, Inc., where he focuses on developing innovative solutions in the medical sector. His work has led to significant advancements, particularly in the area of cancer treatment.
Latest Patents
Michael Deprima holds a patent for "ANTI-ERBB3 ANTIBODIES." This invention represents a crucial step in the development of targeted therapies for cancer patients, showcasing his commitment to improving healthcare outcomes.
Career Highlights
Throughout his career, Deprima has demonstrated a strong dedication to research and innovation. His role at Aveo Pharmaceuticals, Inc. has allowed him to collaborate with other talented professionals in the industry, further enhancing his contributions to biotechnology.
Collaborations
Some of his notable coworkers include Sylvie Vincent and William M Winston, Jr. Their collective expertise has fostered a collaborative environment that drives innovation and research at Aveo Pharmaceuticals, Inc.
Conclusion
Michael Deprima's work exemplifies the impact of innovation in biotechnology. His patent and collaborations highlight his significant role in advancing medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile